Keywords
How to Cite
Abstract
Breast cancer is characterized by the abnormal, rapid and disordered proliferation of breast tissue cells. The disease develops as a result of genetic changes. In its normal functioning, the body replaced old cells with new, healthy cells. Objective: To investigate the clinical and epidemiological scenario of mortality from breast neoplasms between the years 2019 and 2023. Methodology: This is an epidemiological study, of descriptive character with information obtained through the Hospital Admissions System by the Department of Informatics of the Unified Health System (DATASUS), analyzing the epidemiological scenario of mortality due to malignant breast neoplasms in Brazil, in a time frame from 2019 to 2023, filtered according to the International Classification of Diseases and Related Health Problems (ICD-10), the code used was Malignant breast neoplasms. Data on deaths due to malignant breast neoplasms were analyzed in Brazil, which presented a number of 29,820 deaths. Results and Discussion: Data on mortality from malignant breast neoplasms between 2019 and 2023 were analyzed, where it was possible to estimate 2.1 million new cases of cancer and 627 thousand deaths from the disease. The year 2022 presented the highest death rate with a number of 6,246, among the age groups analyzed the highest rates are between 40 and 69 years old with a higher percentage among the white race. The southeast region leads the ranking with 16,351 deaths. Conclusion: It is understood that some factors may be directly associated with the high number of deaths from malignant neoplasms caused by breast cancer, such as age group. Investment in health education is necessary to inform society about the importance of breast cancer care and screening. Screening strategies will help reduce cases of neoplasms and act to reduce the number of deaths, thus ensuring early diagnosis. .
References
ANOTHAISINTAWEE, T. et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia-Pacific Journal of Public Health, Hong Kong, v. 25, n. 5, p. 368-387, 2013. Disponível em: https://journals.sagepub.com/doi/pdf/10.1177/1010539513488795. Acesso em: 14 jun. 2021.
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790-801.
BREAST CANCER ASSOCIATION CONSORTIUM et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. The New England Journal of Medicine, Boston, v. 384, n. 5, p. 428-439, Feb 2021. DOI 10.1056/NEJMoa1913948. Disponível em: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1913948?articleTools=true . Acesso em: 14 jun. 2021.
Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537-48. doi: 10.1007/ s10549-019-05340-7.
FERREIRA, Camila; RODRIGUES, Aldenora Maria Ximenes. Evolução da mortalidade por neoplasias entre os anos de 2010 a 2020 no Brasil segundo sexo e localização primária do tumor. Revista de Ciências Médicas e Biológicas, v. 22, n. 2, p. 181-187, 2023.
INSTITUTO NONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. Detecção precoce do câncer. Rio de Janeiro: INCA, 2021. Disponível em: https://www.inca.gov.br/publicacoes/livros/deteccao-precoce-do-cancer.
INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. Diretrizes para a detecção precoce do câncer de mama no Brasil. Rio de Janeiro: INCA, 2015. Disponível em: https://www.inca.gov.br/publicacoes/livros/diretrizes-para-deteccao-precoce-do-cancer-de-mama-no-brasil.
INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação. Brasil. 2022. Disponível em: https://www.inca.gov.br/publicacoes/livros/situacao-do-cancer-de-mama-no-brasil-sintese-de-dados-dos-sistemas-de-informacao.
INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. Atlas da mortalidade. Rio de Janeiro: INCA, 2022. Base de dados. Disponível em:
https://www.inca.gov.br/app/mortalidade Acesso em: 21 jul 2022.
Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B, et al. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017;24(4):549-53. doi: 10.26444/aaem/75943.
Luizaga, Carolina Terra de Moraes; BUCHALLA, Cassia Maria. Estimativa da incidência de câncer no Estado de São Paulo, Brasil, a partir de dados reais. Cadernos de Saúde Pública, v. 39, 2023.
Migovski A, Dias MB, Nadanovsky P, Silva GA, Sant’Ana DR, Stein AT. Diretrizes para detecção precoce do câncer de mama no Brasil. III – Desafios à implementação. Cad Saúde Pública. 2018;34(6):e00046317.
Silva, Gabriela Rodarte Pedroso da et al. Tendência da taxa de mortalidade por câncer de mama em mulheres com 20 anos ou mais no Brasil, 2005-2019. Ciência & Saúde Coletiva, v. 29, p. e01712023, 2024.
Sociedade Brasileira de Mastologia. Câncer de mama no Brasil. 2024. Disponível em: https://www.sbmastologia.com.br/o-cancer-de-mama/
WORLD HEALTH ORGANIZATION. Early detection. Geneva: WHO, 2007. (Cancer control: knowledge into action: WHO guide for effective programmes, module 3). Disponível em: https://apps.who.int/iris/bitstream/handle/10665/43743/9241547338_eng.pdf?sequence=1.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Maiane Damasceno Costa, Maira Damasceno Costa , Maria da Silva Ericeira , Wendryus William De Lima , Luísa Mendes Reis , José Mário Delaiti de Melo , Janaína Inácio da Silva , Cleonice de Macedo Lopes Silva , Cícera Andressa Meac , Georgia Mayara Leandro Alves , Viviane Maria Principe Crucinsky , Elizilda de Jesus Machado Mariot